The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
Will prices on food, pharmaceuticals and electronics go up in Florida after President Trump's 25% tariffs on goods from ...
A front-of-package food label would be a great educational tool. The Trump administration should keep it.
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
You may have heard in the news that the U.S. Food and Drug Administration will no longer allow the use of FD&C Red Dye No. 3 ...
The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction ...
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...
The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers ...
Numerous food recalls were initiated nationwide this month due to undeclared allergens, potential Salmonella and Listeria contamination concerns, possible foreign matter contaminations among other ...